Aquatic Capital Management LLC Increases Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Aquatic Capital Management LLC boosted its holdings in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 589.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 22,745 shares of the company's stock after purchasing an additional 19,445 shares during the quarter. Aquatic Capital Management LLC's holdings in Revvity were worth $2,539,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. Assetmark Inc. raised its holdings in Revvity by 3,700.0% during the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after buying an additional 259 shares during the period. Millstone Evans Group LLC bought a new position in Revvity during the 4th quarter worth about $38,000. MassMutual Private Wealth & Trust FSB increased its holdings in Revvity by 55.9% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock valued at $43,000 after buying an additional 138 shares during the period. EverSource Wealth Advisors LLC raised its position in shares of Revvity by 33.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock worth $58,000 after acquiring an additional 131 shares in the last quarter. Finally, GeoWealth Management LLC bought a new stake in shares of Revvity in the 4th quarter valued at about $60,000. Hedge funds and other institutional investors own 86.65% of the company's stock.

Revvity Stock Up 1.2 %

RVTY stock traded up $1.14 during mid-day trading on Friday, reaching $94.04. The company had a trading volume of 944,884 shares, compared to its average volume of 929,707. Revvity, Inc. has a fifty-two week low of $88.53 and a fifty-two week high of $129.50. The firm has a fifty day simple moving average of $103.23 and a 200 day simple moving average of $112.33. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. The company has a market capitalization of $11.30 billion, a price-to-earnings ratio of 42.55, a price-to-earnings-growth ratio of 3.82 and a beta of 1.07.

Revvity (NYSE:RVTY - Get Free Report) last issued its earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The business had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. During the same quarter last year, the company earned $0.98 EPS. The business's quarterly revenue was up 2.3% on a year-over-year basis. Analysts forecast that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is currently 11.91%.

Analyst Ratings Changes

Several brokerages recently issued reports on RVTY. KeyCorp upped their target price on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Barclays decreased their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Robert W. Baird cut their target price on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a report on Tuesday. Raymond James restated an "outperform" rating and issued a $120.00 price target (down previously from $145.00) on shares of Revvity in a research note on Tuesday. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a report on Tuesday. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Revvity presently has an average rating of "Moderate Buy" and a consensus price target of $125.64.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.